STOCK TITAN

Penumbra, Inc. to Present at Upcoming Investor Conferences

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences

ALAMEDA, Calif., April 25, 2023 /PRNewswire/ -- Penumbra, Inc. (NYSE: PEN) today announced that its management team is scheduled to present at the following investor conferences on the dates and times listed below:

Event:

Bank of America Securities 2023 Health Care Conference

Date:

Tuesday, May 9, 2023

Time:

1:40pm ET / 10:40am PT



Event:

2023 RBC Capital Markets Global Healthcare Conference

Date:

Tuesday, May 16, 2023

Time:

11:30am ET / 8:30am PT

Webcasts of the presentations will be available by visiting the investors' section of the company's website at www.penumbrainc.com.  The webcasts will be available on the company's website for at least two weeks following the event.

About Penumbra
Penumbra, Inc., headquartered in Alameda, California, is a global healthcare company focused on innovative therapies. Penumbra designs, develops, manufactures and markets novel products and has a broad portfolio that addresses challenging medical conditions in markets with significant unmet need. Penumbra supports healthcare providers, hospitals and clinics in more than 100 countries. For more information, visit www.penumbrainc.com and connect on Twitter and LinkedIn.

Investor Relations

Penumbra, Inc.
510-995-2461
investors@penumbrainc.com

 

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/penumbra-inc-to-present-at-upcoming-investor-conferences-301805981.html

SOURCE Penumbra, Inc.

Penumbra, Inc.

NYSE:PEN

PEN Rankings

PEN Latest News

PEN Stock Data

8.08B
37.19M
3.82%
89.81%
4.98%
Surgical and Medical Instrument Manufacturing
Manufacturing
Link
United States of America
ALAMEDA

About PEN

penumbra is a specialty interventional therapies company that develops and markets innovative medical devices to treat challenging medical conditions with significant unmet clinical needs. we design our therapies to provide our specialist physician customers with improved clinical outcomes through faster and safer procedures at significant overall cost savings to the healthcare system. today we have over 1,000 employees with sales operations in north america, europe, australia and asia.